2003
DOI: 10.1021/ja0210998
|View full text |Cite
|
Sign up to set email alerts
|

Sequence-Selective DNA Cleavage by a Chimeric Metallopeptide

Abstract: A chimeric metallopeptide derived from the sequences of two structurally superimposable motifs was designed as an artificial nuclease. Both DNA recognition and nuclease activity have been incorporated into a small peptide sequence. P3W, a 33-mer peptide comprising helices alpha2 and alpha3 from the engrailed homeodomain and the consensus EF-hand Ca-binding loop binds one equivalent of lanthanides or calcium and folds upon metal binding. The conditional formation constants (in the presence of 50 mM Tris) of P3W… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
80
0

Year Published

2005
2005
2014
2014

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 100 publications
(83 citation statements)
references
References 60 publications
3
80
0
Order By: Relevance
“…[8] Imperiali and co-workers optimized the sequence of lanthanide-binding tags (LBTs) by using screening methods starting from Ca 2 + -binding sites to obtain the highest possible affinity. [9,10] Abstract: Unnatural metal-chelating amino acids bearing aminodiacetate side-chains have been introduced into two hexapeptides to obtain efficient lanthanide-binding peptides.…”
Section: Introductionmentioning
confidence: 99%
“…[8] Imperiali and co-workers optimized the sequence of lanthanide-binding tags (LBTs) by using screening methods starting from Ca 2 + -binding sites to obtain the highest possible affinity. [9,10] Abstract: Unnatural metal-chelating amino acids bearing aminodiacetate side-chains have been introduced into two hexapeptides to obtain efficient lanthanide-binding peptides.…”
Section: Introductionmentioning
confidence: 99%
“…Among the different therapeutic strategies to eradicate cancer cells through DNA damage, the view of using small water soluble transition metal complexes, capable of oxidative or hydrolytic DNA cleavage as anticancer drugs is a challenging issue in bioinorganic chemistry [24,25]. Many transition metal complexes with vanadium [26], iron [27], copper [28,29], cobalt [30], lanthanides [31,32] and also actinides [33] have been reported as efficient DNA cleavage agents with or without sequence specificity, moreover the ligand or the metal in these complexes can be varied in an easily controlled manner to facilitate the individual applications [34].…”
Section: Introductionmentioning
confidence: 99%
“…[4,5] Among the different therapeutic strategies to eradicate cancer cells through DNA damage, the view of using small water-soluble transition-metal complexes, capable of oxidative or hydrolytic DNA cleavage as anti-cancer drugs, is a challenging topic in bioinorganic chemistry. [6,7] Many transition-metal complexes with V, [8] Fe, [9] Cu, [10,11] Co, [12] lanthanides, [13,14] and also actinides [15] have been reported as efficient DNA cleaving agents with or without sequence specificity. Of these metals, zinc is the second most abundant transition-metal ion present in the human body, [16,17] and is in the active sites of several enzymes such as superoxide dismutase, proteins containing zinc finger motifs and zinc hydrolases, in particular, owing to its Lewis acid character.…”
Section: Introductionmentioning
confidence: 99%